Elexacaftor - Tezacaftor - Ivacaftor treatment improves systemic infection parameters and <i>Pseudomonas aeruginosa</i> colonization rate in patients with cystic fibrosis a monocentric observational study.

Heliyon · 2023 · PMC10160512 · PMID 37153441

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In our patient cohort, we detected a highly significant reduction of sweat chloride.

also in 132,142 other papers

showed a trendno p-value reported

Moreover, the average levels of serum sodium showed a trend for an increase in the therapy course, whereas serum chloride did not change.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.